cdmo.directory
← Compare landing

CordenPharma vs Siegfried Holding

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryCordenPharmaSiegfried Holding
SummaryFull-service CDMO offering cGMP development and manufacturing of APIs, lipid excipients, drug products, injectables, peptides, LNPs, oligonucleotides, and oral solid dose across 10 facilities in 6 countries with 3000+ employees.Global CDMO with 16 production sites across four continents, offering integrated development and manufacturing from early-phase to commercial scale for drug substance and drug product.
Services
  • Small Molecule Development & Manufacturing
  • API Synthesis & Manufacturing
  • HPAPI Manufacturing (High-Potency)
  • Flow Chemistry & Continuous Manufacturing
  • Solid-State Chemistry & Polymorph Screening
  • Lipid Nanoparticle (LNP) Formulation
  • Oligonucleotide Manufacturing
  • Peptide Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Vial Filling
  • Prefilled Syringe (PFS) Filling
  • Lyophilization (Freeze Drying)
  • Oral Solid Dosage Manufacturing
  • Inhalation & Nasal Dosage Manufacturing
  • Process Development
  • Formulation Development
  • Technology Transfer
  • CMC Analytical Development
  • Secondary Packaging & Labeling
  • Serialization & Track-and-Trace
  • CMC Regulatory Submission Support
  • Small Molecule Development & Manufacturing
  • API Synthesis & Manufacturing
  • HPAPI Manufacturing (High-Potency)
  • Controlled Substance Manufacturing
  • Flow Chemistry & Continuous Manufacturing
  • Viral Vector Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Vial Filling
  • Oral Solid Dosage Manufacturing
  • Inhalation & Nasal Dosage Manufacturing
  • Ophthalmic Manufacturing
  • Process Development
  • Formulation Development
  • Technology Transfer
  • CMC Analytical Development
  • Quality Control Testing
  • Cold-Chain Storage & Logistics
  • CMC Regulatory Submission Support
Modalities
  • Small Molecule
  • Biologics (Other)
  • Oligonucleotide
  • mRNA
  • Peptide
  • Small Molecule
  • Gene Therapy
Development capabilities
  • Analytical method development
  • Formulation development
  • Solid-state characterization
  • Analytical method development
  • Formulation development
Manufacturing capabilities
  • Drug Substance (DS)
  • Drug Product (DP)
  • Liquid Vials
  • Lyophilized Vials
  • Oral Solid Dose (OSD)
  • Prefilled Syringes (PFS)
  • HPAPI
  • Flow Chemistry
  • Drug Substance (DS)
  • Drug Product (DP)
  • Liquid Vials
  • Oral Solid Dose (OSD)
  • Max chemical: Commercial (>100 kg / tonne)
  • HPAPI
  • DEA licensed
  • Hydrogenation
  • Cryogenic (−80 °C)
  • Flow Chemistry
Locations
  • Global Network
  • Headquarters, Zofingen, Aargau, Switzerland
  • Drug Substances & R&D, Evionnaz, Valais, Switzerland
  • Viral Vector Manufacturing, Schlieren, Zurich, Switzerland
  • Drug Products, Hameln, Lower Saxony, Germany
  • Drug Substances, Minden, North Rhine-Westphalia, Germany
  • Drug Substances, St. Vulbas, Auvergne-Rhône-Alpes, France
Certifications
  • cGMP · Identifier: cGMP certified facilities
  • FDA · Identifier: cGMP
  • FDA · Identifier: U.S. Food and Drug Administration
  • Swissmedic · Identifier: Swissmedic
  • PMDA · Identifier: Japan's Pharmaceuticals and Medical Devices Agency
  • AEMPS · Identifier: Spanish Agency of Medicines and Medical Devices

Find similar companies

CordenPharma alternatives · Siegfried Holding alternatives

Markdown mirror: /compare/cordenpharma/siegfried.md